# DNX-2440 Oncolytic Adenovirus for Recurrent Glioblastoma

> **NCT03714334** · PHASE1 · TERMINATED · sponsor: **Clinica Universidad de Navarra, Universidad de Navarra** · enrollment: 16 (actual)

## Conditions studied

- Glioblastoma
- Glioblastoma, Adult

## Interventions

- **DRUG:** DNX-2440 injection

## Key facts

- **NCT ID:** NCT03714334
- **Lead sponsor:** Clinica Universidad de Navarra, Universidad de Navarra
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-10-16
- **Primary completion:** 2023-04-05
- **Final completion:** 2023-04-05
- **Target enrollment:** 16 (ACTUAL)
- **Why stopped:** Break of stock
- **Last updated:** 2023-04-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03714334

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03714334, "DNX-2440 Oncolytic Adenovirus for Recurrent Glioblastoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03714334. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*